Z Liu, X X Fu, N L Zhang
Index: Zhongguo Zhong Xi Yi Jie He Za Zhi 16(12) , 738-40, (1996)
Full Text: HTML
Co-Cinobufotalin Oral Liquor (CCOL) was studied for its ability to inhibit hepatitis B virus DNA replication, HBsAg and HBeAg expression in a HBV-transfected cell line (2.2.15 cell). The result showed that ID50 (the drug concentration that inhibits HBsAg or HBeAg secretion by 50%) was 0.08 mg/ml and 0.07 mg/ml on HBsAg and HBeAg respectively. CD50 (the drug concentration that reduces cell growth by 50%) was 2.5 mg/ml. TI (therapeutic index) was 31.3 and 35.7 respectively. The present data suggest that CCOL could exert a potent antiviral activity against HBV in vitro. Southern blot showed that CCOL inhibited HBV-DNA repication in a dose-dependent manner.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cinobufotalin
CAS:1108-68-5 |
C26H34O7 |
Pre-clinical evaluation of cinobufotalin as a potential anti...
2014-09-26 [Biochem. Biophys. Res. Commun. 452(3) , 768-74, (2014)] |
Ceramide production mediates cinobufotalin-induced growth in...
2015-08-01 [Tumour Biol. 36 , 5763-71, (2015)] |
Comparative Analysis of the Bufonis Venenum by Using TLC, HP...
2012-12-01 [J Pharmacopuncture 15 , 52-65, (2015)] |
Chemical defense of an Asian snake reflects local availabili...
2013-04-01 [J. Zool. (Lond.) 289 , 270-278, (2013)] |
[Clinical study on cinobufotalin in treating chronic hepatit...
1993-08-01 [Zhongguo Zhong Xi Yi Jie He Za Zhi 13(8) , 473-5, 453-4, (1993)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved